Guide

Biosimilars pipeline report: A guide for understanding the growing market

To date, there have been 63 approvals and 44 launches in the U.S. biosimilars market. 

Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options. As this market matures, its pipeline continues to grow. This reference guide is a useful tool to visualize and understand the current product landscape and potential future of this emerging market.
We keep this report up to date as the biosimilars market evolves. Enter your information below to receive the newest versions to your inbox as they're released.
Pardot Form

We are Cencora. Our shared identity unites us.

Cencora brings the companies and services of AmerisourceBergen together under one new name.
Manufacturer of biosimilars

Learn more about our biosimilar solutions

We believe in the promise of biosimilars to deliver cost savings across healthcare. We also understand the potential hurdles these unique products will face. That's why we offer solutions for increasing access to and confidence in these emerging therapies.
Landscape of biosimilars

The landscape of available biosimilars

In this white paper, we delve into the concept of biosimilars, their distinctions from generics, their impact on reimbursement policies, and the challenges and opportunities they present to healthcare providers, payers, and manufacturers.

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.

Related resources

White paper

Capitalizing on biotech collaboration: A CFO’s guide to driving growth
Learn More

Article

The future promise of advanced therapies in ophthalmology
Learn More

Article

Unlock the future of formulary decision-making with AI
Learn More

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.